Interpace Biosciences, Inc.
IDXG
$1.25
$0.00280.23%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -58.01% | -60.25% | -49.75% | -27.55% | -20.24% |
Total Receivables | 50.99% | 12.24% | 6.17% | -0.97% | 0.79% |
Inventory | 11.62% | 4.59% | -1.70% | 0.25% | -12.28% |
Prepaid Expenses | 0.23% | 3.89% | 18.35% | 51.28% | 94.69% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 0.00% | -92.15% | -91.52% | -96.47% | -74.10% |
Total Current Assets | -2.87% | -21.65% | -24.58% | -15.07% | -10.21% |
|
|||||
Total Current Assets | -2.87% | -21.65% | -24.58% | -15.07% | -10.21% |
Net Property, Plant & Equipment | 5.26% | 2.41% | -4.39% | -9.08% | 111.58% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -100.00% | -97.71% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | -43.75% |
Total Assets | -1.48% | -18.63% | -23.52% | -18.51% | -6.82% |
|
|||||
Total Accounts Payable | 25.81% | 4.26% | -13.84% | 47.05% | -6.50% |
Total Accrued Expenses | 19.15% | 14.86% | 15.93% | 14.47% | 4.22% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1,347.58% | 265.57% | 187.13% | 77.94% | -86.93% |
Total Finance Division Other Current Liabilities | -54.82% | -48.85% | -44.90% | -37.49% | 0.84% |
Total Other Current Liabilities | -54.82% | -48.85% | -44.90% | -37.49% | 0.84% |
Total Current Liabilities | 52.30% | 40.29% | 36.98% | 22.34% | -16.79% |
|
|||||
Total Current Liabilities | 52.30% | 40.29% | 36.98% | 22.34% | -16.79% |
Long-Term Debt | -- | -- | -87.94% | -62.00% | 15.79% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -23.59% | -21.87% | -22.25% | -20.35% | 745.65% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 5.62% | 1.02% | -1.48% | -4.81% | -7.81% |
Total Liabilities | -17.14% | -19.45% | -16.10% | -13.40% | 0.14% |
|
|||||
Common Stock & APIC | 0.18% | 0.22% | 0.27% | 0.34% | 0.33% |
Retained Earnings | 1.89% | 1.13% | 0.37% | 0.32% | -0.67% |
Treasury Stock & Other | -2.45% | -1.96% | -1.96% | -1.62% | -3.26% |
Total Common Equity | 7.97% | 5.11% | 2.23% | 2.22% | -1.76% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|||||
Total Common Equity | 7.97% | 5.11% | 2.23% | 2.22% | -1.76% |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 30.96% | 20.29% | 8.73% | 8.47% | -7.22% |
|